Pure Global

Fluorescence In Situ Hybridization, Anaplastic Lymphoma Kinase, Gene Rearrangement

Fluorescence In Situ Hybridization, Anaplastic Lymphoma Kinase, Gene Rearrangement is a medical device type in the Unknown specialty. This page includes real-world medical device registration data worldwide for this device type, with registrations from US FDA, Brazil ANVISA, and other global markets.

View regulatory classifications, recent 510(k) clearances, active device registrations, and similar products registered globally under this device category. Pure Global AI's free directory provides comprehensive worldwide registration intelligence across 7,000+ medical device types and 21 specialties.

Global Registration Data
Multi-Country Intelligence
Fluorescence In Situ Hybridization, Anaplastic Lymphoma Kinase, Gene Rearrangement
Unknown Medical Device Type
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Regulatory Classifications

US Regulatory Classifications

OWE

View Product Code Classification

Class 3

21 CFR

View CFR Regulation

Unknown

Device Characteristics

No

No

No

Not Eligible

Definition

Anaplastic lymphoma kinase (ALK) fluorescence in situ hybridization (FISH) kit is to detect rearrangements involving the ALK gene in formalin-fixed, paraffin-embedded (FFPE) non-small cell lung cancer (NSCLC) tissue specimens. It is indicated to aid in the selection of patients for treatment with specific FDA approved therapeutic drugs.